Myland Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-12-2024
- Paid Up Capital ₹ 1.26 M
as on 17-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
About Myland Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.26 M, as per Ministry of Corporate Affairs (MCA) records.
Jaggavarapu Parvathidevi, Garugu Reddy, and Sanjeeva Jagavarappu serve as directors at the Company.
- CIN/LLPIN
U24297TG2020PTC141872
- Company No.
141872
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Myland Life Sciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jaggavarapu Parvathidevi | Director | 18-Nov-2020 | Current |
Garugu Reddy | Director | 12-Feb-2021 | Current |
Sanjeeva Jagavarappu | Director | 18-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Myland Life Sciences.
Enhance accessibility to Myland Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Myland Life Sciences?
Unlock access to Myland Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Myland Pharma Private LimitedActive 4 years 5 months
Jaggavarapu Parvathidevi and Sanjeeva Jagavarappu are mutual person
- Innovera Life Sciences Private LimitedActive 7 years 3 months
Jaggavarapu Parvathidevi and Sanjeeva Jagavarappu are mutual person
- Ziras Technologies Private LimitedActive 9 years 20 days
Jaggavarapu Parvathidevi and Sanjeeva Jagavarappu are mutual person
- Myland Organics Private LimitedActive 3 years 6 months
Jaggavarapu Parvathidevi and Sanjeeva Jagavarappu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Myland Life Sciences?
Myland Life Sciences has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Myland Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myland Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.